Rendering

Component: (Network and Table)
Network
2307301 - Disclosure - LONG-TERM DEBT (Tables)
(http://www.arraybiopharma.com/role/LongTermDebtTables)
Table(Implied)
Slicers (applies to each fact value in each table cell)
Debt Disclosure [Abstract]Period [Axis]
2015-07-01 - 2016-06-30
Debt Disclosure [Abstract]
 
Schedule of long-term debt
Long-term debt consists of the following (in thousands):
 
June 30,
 
2016
 
2015
 
 
 
 
Comerica term loan
$
14,550

 
$
14,550

Convertible senior notes
132,250

 
132,250

Long-term debt, gross
146,800

 
146,800

Less: Unamortized debt discount and fees
(33,145
)
 
(39,520
)
Long-term debt, net
$
113,655

 
$
107,280

 
 
Schedule of interest expense
The following table shows the details of our interest expense for all of our debt arrangements outstanding during the periods presented, including contractual interest, and amortization of debt discount, debt issuance costs and loan transaction fees that were charged to interest expense (in thousands):
 
Year Ended June 30,
 
2016
 
2015
 
2014
Comerica Term Loan
 
 
 
 
 
Simple interest
$
501

 
$
480

 
$
479

Amortization of fees paid for letters of credit
31

 
44

 
48

Total interest expense on the Comerica term loan
532

 
524

 
527

 
 
 
 
 
 
Convertible Senior Notes
 
 
 
 
 
Contractual interest
3,967

 
3,968

 
3,979

Amortization of debt discount
6,033

 
5,447

 
4,932

Amortization of debt issuance costs
342

 
308

 
278

Total interest expense on the convertible senior notes
10,342

 
9,723

 
9,189

Total interest expense
$
10,874

 
$
10,247

 
$
9,716

 
 
Schedule of principal payments required for long-term debt
We are required to make principal payments for our long-term debt as follows during the fiscal years ending June 30 (in thousands):
 
Principal Due
 
 
2017
$

2018
14,550

2019

2020
132,250

2021

Thereafter

 
$
146,800